Can confirm — my data shows the same pattern.

ChrisMacros said:

I started my GLP-1 journey in March 2025 at 280 lbs with metabolic syndrome

Gonna push back on this one. Novo Nordisk CagriSema Phase 3 is not that straightforward in my experience. I have been on this for 12 months and the reality is messier than the trials suggest.

Don't get me wrong — the medication works. But cost accessibility is a real barrier. We should be honest about that.

Want to share my personal experience related to Novo Nordisk CagriSema Phase 3 since I think it might help others in a similar situation.

I started my GLP-1 journey in October 2024 at 286 lbs with prediabetes and hypertension. My endocrinologist prescribed semaglutide 0.25mg to start.

Now, 6 months later: I am down 46 lbs, my labs have normalized, and I am off 2 of my 3 medications. The Novo Nordisk aspect specifically was something that made a big difference in my journey.

This community helped me every step of the way.

Saving this for reference. Top-tier content.

wei_SG — that is really helpful context on Novo Nordisk CagriSema. Follow-up question: what labs did your doctor order to monitor this?

I am in a similar situation (just started) and trying to set realistic expectations.